{"nct_id":"NCT06305754","title":"Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-06-11","start_date_type":"ACTUAL","primary_completion_date":"2028-09-12","primary_completion_date_type":"ESTIMATED","completion_date":"2030-06-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}